Piper Sandler Initiates Coverage On Matinas BioPharma Hldgs with Overweight Rating, Announces $3 Price Target

Piper Sandler analyst Edward Tenthoff initiates coverage on Matinas BioPharma Hldgs (AMEX:MTNB) with a Overweight rating and a $3 price target.

Benzinga · 01/27/2020 11:49

Piper Sandler analyst Edward Tenthoff initiates coverage on Matinas BioPharma Hldgs (AMEX:MTNB) with a Overweight rating and a $3 price target.